Current Status of Bill HR 4813
Bill HR 4813 is currently in the status of Bill Introduced since July 29, 2021. Bill HR 4813 was introduced during Congress 117 and was introduced to the House on July 29, 2021. Bill HR 4813's most recent activity was Referred to the Subcommittee on Health. as of July 30, 2021
Bipartisan Support of Bill HR 4813
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
1Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
2Republican Cosponsors
0Unaffiliated Cosponsors
0
Policy Area and Potential Impact of Bill HR 4813
Primary Policy Focus
Health
Alternate Title(s) of Bill HR 4813
To limit the price of insulin drugs accessible for participants, beneficiaries, and enrollees enrolled in group or individual health insurance coverage and group health plans and for uninsured individuals who have diabetes, and for other purposes.Matt’s ActMatt’s Act